EUVIMEDEUVIMED entdecken
Open Access

An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis

Shuang Wang iD, Kenneth Li iD, Eliana Pickholz, Ross Dobie, Kylie P Matchett iD, Neil C Henderson iD, Chris Carrico, Ian Driver iD, Martin Borch Jensen, Li Chen iD, Mathieu Petitjean iD, Dipankar Bhattacharya und 7 weitere

Science Translational Medicine · 04.01.2023 · 15 (677)

DOI: 10.1126/scitranslmed.add3949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 04.01.2023. Verfasst von Shuang Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 182-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Cancer Research UK, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced hepatic fibrosis, driven by the activation of hepatic stellate cells (HSCs), affects millions worldwide and is the strongest predictor of mortality in nonalcoholic steatohepatitis (NASH); however, there are no approved antifibrotic therapies. To identify antifibrotic drug targets, we integrated progressive transcriptomic and morphological responses that accompany HSC activation in advanced disease using single-nucleus RNA sequencing and tissue clearing in a robust murine NASH model. In advanced fibrosis, we found that an autocrine HSC signaling circuit emerged that was composed of 68 receptor-ligand interactions conserved between murine and human NASH. These predicted interactions were supported by the parallel appearance of markedly increased direct stellate cell-cell contacts in murine NASH. As proof of principle, pharmacological inhibition of one such autocrine interaction, neurotrophic receptor tyrosine kinase 3–neurotrophin 3, inhibited human HSC activation in culture and reversed advanced murine NASH fibrosis. In summary, we uncovered a repertoire of antifibrotic drug targets underlying advanced fibrosis in vivo. The findings suggest a therapeutic paradigm in which stage-specific therapies could yield enhanced antifibrotic efficacy in patients with advanced hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansMiceAnimalsHepatic Stellate CellsAutocrine CommunicationFibrosisLiver CirrhosisLiver

Autor:innen und Institutionen

  • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • Gordian Biotechnology, San Francisco, CA 94107, USA.
  • PharmaNest Inc., Princeton, NJ 08540, USA.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

ORCID-Profile: Shuang Wang, Kenneth Li, Kylie P Matchett, Neil C Henderson, Ian Driver, Li Chen, Mathieu Petitjean, Maria I Fiel, Xiao Liu, Ruslan Medzhitov, Scott L Friedman

Förderung

  • NIDDK NIH HHS
  • Cancer Research UK
  • NIAAA NIH HHS
  • NCATS NIH HHS
  • Wellcome Trust
  • NCI NIH HHS

Zitieren

APA

Wang, S., Li, K., Pickholz, E., Dobie, R., Matchett, K. P., Henderson, N. C., Carrico, C., Driver, I., Borch Jensen, M., Chen, L., Petitjean, M., Bhattacharya, D., Fiel, M. I., Liu, X., Kisseleva, T., Alon, U., Adler, M., Medzhitov, R., & Friedman, S. L. (2023). An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine, 15(677). https://doi.org/10.1126/scitranslmed.add3949

Vancouver

Wang S, Li K, Pickholz E, Dobie R, Matchett KP, Henderson NC, et al. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine. 2023;15(677). doi:10.1126/scitranslmed.add3949

BibTeX
@article{Wang2023,
  author = {Wang, Shuang and Li, Kenneth and Pickholz, Eliana and Dobie, Ross and Matchett, Kylie P and Henderson, Neil C and Carrico, Chris and Driver, Ian and Borch Jensen, Martin and Chen, Li and Petitjean, Mathieu and Bhattacharya, Dipankar and Fiel, Maria I and Liu, Xiao and Kisseleva, Tatiana and Alon, Uri and Adler, Miri and Medzhitov, Ruslan and Friedman, Scott L},
  title = {An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {677},
  doi = {10.1126/scitranslmed.add3949}
}
Kostenlos starten →